|
Volumn 3, Issue 4, 2003, Pages 291-298
|
SHIP2: an emerging target for the treatment of type 2 diabetes mellitus.
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
INPPL1 PROTEIN, HUMAN;
INSULIN;
PHOSPHATASE;
ANIMAL;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
HUMAN;
METABOLISM;
METHODOLOGY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PHYSIOLOGY;
REVIEW;
SIGNAL TRANSDUCTION;
ANIMALS;
DIABETES MELLITUS, TYPE 2;
DRUG DELIVERY SYSTEMS;
HUMANS;
INSULIN;
PHOSPHORIC MONOESTER HYDROLASES;
SIGNAL TRANSDUCTION;
|
EID: 1542780541
PISSN: 15680088
EISSN: None
Source Type: Journal
DOI: 10.2174/1568008033340144 Document Type: Review |
Times cited : (10)
|
References (65)
|